http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-994743-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7780e9d205ef3d354fe484bbc65b155c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00
filingDate 1961-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1965-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-994743-A
titleOfInvention Cyclopentanophenanthrene compounds and process for their production
abstract The invention comprises 16a -mono-di- and trifluorome hyl pregnanes of the formulae <FORM:0994743/C2/1> (in which X represents a mono-, di- or trifluoromethyl radical; Z and Z1 represent a double bond or saturated linkage between C1 and C2, and C6 and C7 respectively; R1 is hydrogen, methyl, fluorine or chlorine; and R and R11 represent hydrogen or an acyl radical of a hydrocarbon carboxylic acid of less than 12 carbon atoms, e.g. acetate, benzoate, aminoacetate, b -chloropropionate; with the proviso that when #C is a monofluoromethyl group in compounds bearing a 21-hydroxy or acyloxy substituent, R1 is limited to fluorine or chlorine) and methods for the preparation of 16a -trifluoromethyl-and 16a -monofluoromethyl-derivatives of the pregnane series by reacting a D 16-pregnen-20-one with a trifluoromethyl- or monofluoromethyl magnesium halide. Compounds of the formulae <FORM:0994743/C2/2> are prepared from 3b -acetoxy-D 5,16-pregnadien-20-one by treatment with a trifluoromethyl magnesium halide, and then with acetic anhydride/acetyl chloride or acetic anhydride/p-toluene sulphonic acid to give 16a -trifluoromethyl - D 5,17(20) - pregnadiene - 3b ,20b - diol diacetate, which is converted to 16a -trifluoromethyl - D 5 - pregnene - 3b ,17a - diol - 20 - one via the 5,6: 17,20-bisoxidopregnane-3b ,20-diol diacetate and 5,6-oxidopregnane-3b ,17a -diol-20-one; the 3b -hydroxy group is then oxidized to a keto group and the D 5 bond shifted to D 4 to give 16a - trifluoromethyl - D 4 - pregnen - 17a -ol-3, 20-dione. Double bonds at D 1 and/or D 6 may then be introduced, the 17a -hydroxyl may be acylated, and a further hydroxy or acyloxy group introduced at C21 by standard procedures. The synthesis may be modified by the use of monofluoromethyl magnesium halide to give the corresponding 16a -monofluoromethyl derivatives, or by the use of 6-methyl-D 5,16-pregnadien - 3b - ol - 20 - one acetate to give the corresponding 6-methyl analogues. Compounds of the formula <FORM:0994743/C2/3> can be prepared from 16a -trifluoromethyl-D 5-pregnene - 3b ,17a - diol - 20 - one (I) by ketalization at C20, peracid oxidation, treatment of the resulting 5a ,6a -oxide with methyl magnesium bromide, cleavage of the ketal, oxidation of the 3b -hydroxy group and dehydration of the resulting 5a -hydroxy-6b -methyl derivative with concomitant inversion at C6 to give 16a -trifluoromethy - 6a - methyl - D 4 - pregnen-17a - ol - 3,20 - dione, which may then be modified to give the corresponding 21-hydroxy, D 1, D 1,6 or D 6 compounds and esters thereof. The corresponding 16a -monofluoromethyl compounds are obtainable from 16a -monofluoromethyl - D 5 - pregnene - 3b ,17a - diol - 20 - one. Compounds of the formula <FORM:0994743/C2/4> are prepared from I by treatment with N-bromoacetamide and anhydrous HF, xoidation of the resulting 5a -bromo-6b -fluoro compound to the 3-ketone, dehydrobromination at C5 and inversion at C6 to give 6a -fluoro-16a -trifluoromethyl - D 4 - pregnen - 17a - ol - 3,20 - dione, which may then be dehydrogenated at D 1, D 6 or D 1,6 and/or hydroxylated at C21. The corresponding 16a -monofluoromethyl compounds are obtainable from 16a -monofluoromethyl-D 5-pregnene - 3b ,17a - diol - 20 - one. The 6 - fluoro atom may also be introduced by treating a 5a , 6a -oxide with BF3, and the analogous 6-chloro compounds of formulae <FORM:0994743/C2/5> are formed by treating 16a -trifluoro- or monofluoro - methyl - 5a ,6a - oxidopregnane - 3b , 17a -diol-20-one with HCl in acetic acid, oxidizing the resulting 6b -chloro pregnane to 16a -trifluoro-or monofluoromethyl-6b -chloropregname - 5a ,17a - diol - 3,20 - dione, dehydrating the latter and inverting the configuration at C6, and thereafter introducing additional nuclear double bonds and/or a hydroxy group at C21. The 6a -chloro group may also be introduced by treating the ester of 16a -trifluoro- or monofluoro - methyl - D 4 - pregnen - 17a - ol - 3,20-dione with ethyl orthoformate, treating the resulting enol ether with N-chlorosuccinimide and thereafter inverting the configuration of the chlorine atom to form 16a -trifluoro- or monofluoro - methyl - 6a - chloro - 17a - acyloxy - D 4 - pregnene - 3,20 - dione. Compounds of the invention bearing a 16-difluoromethyl group are prepared from the 3-benzoate 20-acetate of D 5-pregnene-3b ,20b -doil-16a -carboxylic acid by treatment with oxalyl chloride followed by reduction of the acid chloride to give the 16a -formyl derivative, which is treated with SF4 in benzene to form 16a -difluoromethyl-D 5 - pregnene - 3b ,20b - diol 3 - benzoate 20-acetate. Saponification and oxidation of the C20 hydroxyl group, followed by saponification and Oppenauer oxidation of the C3 hydroxyl group gives 16a - difluoromethyl progesterone, which is then treated in the same way as the corresponding 16a -trifluoromethyl compound to yield compounds of the general formula <FORM:0994743/C2/6> A methyl, fluorine, or chlorine substituent is introduced at C6 by methods similar to those employed for the corresponding 16-trifluoromethyl compounds. The 3 - benzoate, 20 - acetate of D 5 - pregnene 3b ,20b - diol - 16a - carboxylic acid is prepared from 16a - cyano - D 5 - pregnen - 3b - ol - 20-one acetate by reduction of the 20-keto group, formation of the 20b -tetrahydropyranyl ether, alkaline hydrolysis of the 16-cyano and 3-acetate groups, benzoylation, hydrolysis of the 20b -ether and acetylation of the 20b -hydroxy group. Trifluoromethylmagnesium iodide is prepared from trifluoroiodomethane and magnesium in cooled tetrahydrofuran. Monofluoromethyl magnesium iodide is likewise prepared using fluoroiodomethane. Specifications 776,858, 994,744 and 994,745 are referred to.
priorityDate 1960-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411280324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22796609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20285045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID794595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423008072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154398147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67032353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56993169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424684278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447708632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427801977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22213172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409781413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425755001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423097956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452932707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20164361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450415267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53477678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409432392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23239843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416083423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432527562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450373611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426383625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413305291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408245893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13981373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224

Total number of triples: 84.